The oligomerization of UGTs [UDP (uridine diphosphate)-glucuronosyltransferases] modulates their enzyme activities. Recent findings also indicate that glucuronidation is negatively regulated by the formation of inactive oligomeric complexes between UGT1A enzymes [i1 (isoform 1)] and an enzymatically inactive alternatively spliced i2 (isoform 2). In the present paper, we assessed whether deletion of the UGT-interacting domains previously reported to be critical for enzyme function might be involved in i1-i2 interactions. The bilirubin-conjugating UGT1A1 was used as a prototype. We also explored whether intermolecular disulfide bonds are involved in i1-i2 interactions and the potential role of selected cysteine residues. Co-immunoprecipitation assays showed that UGT1A1 lacking the SP (signal peptide) alone or also lacking the transmembrane domain (absent from i2) did not self-interact, but still interacted with i2. The deletion of other N-or Cterminal domains did not compromise i1-i2 complex formation. Under non-reducing conditions, we also observed formation of HMWCs (high-molecular-mass complexes) for cells overexpressing i1 and i2. The presence of UGTs in these complexes was confirmed by MS. Mutation of individual cysteine residues throughout UGT1A1 did not compromise i1-i1 or i1-i2 complex formation. These findings are compatible with the hypothesis that the interaction between i1 and i2 proteins (either transient or stable) involves binding of more than one domain that probably differs from those involved in i1-i1 interactions.
INTRODUCTION
The functions of most proteins depend on continuous interactions with other proteins or molecules [1] . The study of protein interactomes is a growing field, and numerous studies have attempted to characterize interactomes for various biological processes and/or for different cell types or tissues. The finding that most human genes are subject to alternative pre-mRNA splicing has demonstrated a key process for protein diversity and for regulating various biological processes [2] [3] [4] . Both processes, splicing and protein-protein interactions, reportedly affect smallmolecule biotransforming pathways such as those governed by the superfamily of UGTs [UDP (uridine diphosphate)-glucuronosyltransferases] [5] [6] [7] [8] [9] [10] [11] [12] .
Human UGTs are an important class of conjugating enzymes that play a key role in several important metabolic processes and exhibit broad substrate specificity. Indeed, those enzymes catalyse the glucuronidation of a wide range of structurally unrelated endogenous and xenobiotic chemicals, including numerous therapeutic drugs [13, 14] . UGTs are type I membrane proteins of the ER (endoplasmic reticulum) classified in two major families, UGT1A and UGT2 (2A and 2B) [13] . The ∼ 190-kb UGT1A locus produces half of the enzymatically active human UGT enzymes. Alternative usage of variable first exons encoding the substratebinding domain leads to nine active UGT1A enzymes, known as i1 (isoform 1) [15] . In previous studies, alternative splicing at the 3 -end of this locus was revealed, as a result of the presence of an additional/shorter terminal exon (exon 5b) and leading to nine shorter UGT1A proteins [i2 (isoform 2)] [16, 17] .
UGT1A i2 alternative protein isoforms lack glucuronic acid transferase activity, but are residents of the ER despite lacking the TMD (transmembrane domain) [17] . Functional assays with human cells co-expressing i1 enzymes and i2 variant isoforms have clearly demonstrated a significant decrease in cellular glucuronidation activity for many different UGT1A substrates, supporting a regulatory role for i2 proteins [16] [17] [18] [19] [20] [21] . Furthermore, co-immunoprecipitation experiments support protein-protein interactions between i1 and i2 proteins in heterologous expression systems [17] [18] [19] . Also, the cellular co-localization of UGT1A isoforms supports molecular interaction between them. The mechanism underlying the regulation of transferase activity by splice forms has become even more complex with the recent demonstration of heterodimer formation between all UGT1A i1 and other i2 [19] . Previously reported data thus suggest that glucuronidation is negatively regulated by interactions between active i1 enzymes and alternatively spliced i2 regulatory proteins through formation of enzymatically inactive complexes.
The function of UGTs as oligomeric complexes and their regulation through protein-protein interactions has been documented (for reviews see [11, 22] ). Oligomerization of two inactive mutants was even shown to yield an active enzyme complex [23] . Previous studies point to several potential protein domains that may regulate oligomerization/activity or subcellular localization (Table 1) . For instance, domains of the N-terminal [24] [25] [26] [27] . The MRA is also likely to be involved in UGT oligomerization [28] . Recent protein homology modelling identified a putative dimerization domain for UGT2B7 located between residues 180 and 200 [29] . The C-terminal portion has also been studied. Experiments showed that the Cterminal tail (residues 510-534) and TMD (residues 490-510) are not essential for hetero-oligomerization of UGT [23, 28] , although deletion of one or the other significantly affects enzyme activity [23, 27, 30, 31] . Although protein-protein interactions are typically non-covalent and thus reversible [32, 33] , some studies also suggest that UGT oligomerization could occur via covalent interactions. For instance, the presence of a HMWC (highmolecular-weight complex) under non-reducing conditions in SDS/PAGE suggests the possibility of disulfide bonds between UGTs [23, 28, 34] . On the basis of these observations, we assessed whether deletion of UGT domains reported previously to be critical for enzyme function, oligomerization and cellular localization might mediate protein-protein interactions between i1 and i2. We then explored whether relatively stronger intermolecular disulfide bonds are involved in these interactions and the potential role of specific cysteine residues using site-directed mutagenesis. The bilirubin-conjugating UGT1A1 was used as a prototype. We provide direct experimental evidence that the domain(s) critical for interaction between i1-i2 probably differs from that involved in i1-i1 interactions. The formation of large molecular complexes was further demonstrated, but the identity of the cysteine residues responsible for those interactions remains unknown.
EXPERIMENTAL Preparation of microsomes and SDS/PAGE
Human cells were disrupted by sonication (3× 10 s on ice with a 10 s pause in between each sonication; 550 Sonic Dismembrator, Fisher Scientific) and centrifuged twice at 12 200 g for 20 min to remove the nuclear components cell debris. The ER membrane fraction was then collected by sedimentation of the supernatant at 105 000 g for 1 h. The protein concentration was determined using the Bradford method. The microsomal protein extracts were diluted in 4× non-reducing buffer [6.85 % (v/v) SDS, 233.3 mM Tris/HCl (pH 6.8), 24 % (v/v) glycerol, 0.008 % Bromophenol Blue and resolved by SDS/PAGE (10 % gel)]. Under reducing conditions, samples were heated in the 4× buffer, which was completed with 0.85 % final concentration of 2-mercaptoethanol as a reducing agent. Protein levels in HEK (human embryonic kidney)-293 cells overexpressing either i1-Myc-His alone or i1-Myc-His coexpressed with i2-V5-His were determined by Western blotting using an antibody against either myc (Cedarlane, 1:1500 dilution) or v5 (Life Technologies, 1:5000 dilution).
LC (liquid chromatography)-MS/MS (tandem MS) analysis
SDS/PAGE lanes corresponding to non-reducing conditions of UGT1A1-overexpressing HEK-293 cells were cut into six gel slices per lane. In-gel protein digestion was performed on a MassPrep TM liquid handling station (Waters) according to the manufacturer's instructions and using sequencing-grade modified trypsin (Promega). Cell extracts containing peptides were dried using a SpeedVac ® (Thermo Scientific) and then separated by online reversed-phase nanoscale capillary LC and analysed by electrospray MS/MS as described in [35] . Briefly, an LTQ (linear trap quadrupole) MS (Thermo Electron) equipped with a nanoelectrospray ion source (Thermo Electron) was used. Peptides were separated with a PicoFrit ® column BioBasic C18, 10 cm × 0.075 mm internal diameter (New Objective), with a linear gradient from 2 to 50 % solvent B (acetonitrile and 0.1 % formic acid) over 30 min at 200 nl/min. Each full-scan mass spectrum (400-2000 m/z) was followed by collision-induced dissociation of the seven most intense ions. All MS/MS samples were analysed using Mascot (Matrix Science, version 2.3) with the human UniRef 100 protein database (Homo sapiens: Taxon 9606, 100683 entries) assuming trypsin as the digesting enzyme. Two missed cleavages were allowed. Scaffold (version 03.00.02; Proteome Software) was used to validate MS/MS-based peptide and protein identifications, which were accepted if they could be established at >95.0 % probability as specified by the Peptide Prophet algorithm and contained at least two identified peptides [36] .
Site-directed mutagenesis
Site-directed mutagenesis was carried out to replace specific cysteine residues of i1 cDNA with tyrosine ( Table 2 ). The UGT1A1 cDNA was subjected to oligonucleotide-mediated mutagenesis with turbo Pfu DNA polymerase (DNA polymerase • C for 60 s and 68
• C for 16 min. Site-directed mutagenesis was followed by digestion with DpnI to eliminate parental DNA (Roche Applied Science). Digestion products were then transformed into Escherichia coli XL1 Blue cells. Growing colonies were assessed for the presence of the correct point mutation, which was confirmed by direct sequencing.
Generation of UGT1A1-mutated proteins
Mutated cDNAs for i1-Myc-His and i2-V5-His were generated with overlap extension PCR as described in [37] . This method relies on two oligonucleotides that overlap the deletion to be made. Human UGT1A1 i1 and UGT1A1 i2 were used as a template DNA for the PCR. UGT1A1 i1 was cloned into pcDNA3.1A-MycHis (Life Technologies), whereas UGT1A1 i2 was cloned into pcDNA6A-V5-His (Life Technologies). PCRs were performed on UGT1A1 pcDNA3.1A-Myc-His for i1 or on pcDNA6A-V5-His for i2 cDNA as follows: 95
• C for 5 min, 30 cycles of 95 • C for 30 s, 55
• C for 30 s, 72
• C for 2 min and a final extension at 72
• C for 7 min. All constructs were verified by direct sequencing.
Co-immunoprecipitation assays using proteins from transiently transfected cells
HEK-293 cells were transfected for transient expression using the Neon ® electroporation kit (Life Technologies). Briefly, 7.5× 10 6 cells were mixed with DNA (10 μg of i1 plasmid, 10 μg of i2 or 5 μg each of i1 and i2) and then electroporated at 1300 V for 10 ms (three pulses). After 48 h, the cells were washed with PBS, harvested and lysed for 45 min on ice with 1 ml of lysis buffer [0.05 M Tris/HCl (pH 7.4), 0.15 M NaCl, 0.3 % deoxycholic acid, 1 % (w/v) Igepal CA-630 (Sigma) and 1 mM EDTA]. Cell lysates were then homogenized by pipetting up and down through fine needles (18G followed by 20G) for ten to twenty times on ice. Lysates were centrifuged for 15 min at 13 000 g, and the supernatants were collected. Cell-free lysates were mixed with Protein G-Sepharose ® 4 Fast Flow (50 % slurry; GE Healthcare) and stirred for 30 min at 4
• C to block nonspecific binding. After centrifugation (13 000 g for 1 min), 1 mg of supernatant protein was added to 1 μg of specific polyclonal anti-Myc (Sigma) in 1 ml of lysis buffer and incubated at 4
• C with 50 μl of beads (50 % slurry) for 15 h. The beads were washed three times with 1 ml of lysis buffer and finally with 1 ml of 50 mM Tris/HCl (pH 7.5). The beads containing the immunoprecipitated proteins were resuspended with 30 μl of SDS/PAGE loading buffer, heated at 100
• C for 5 min and then centrifuged at 12 000 g for 20 s. The supernatant was subjected to SDS/PAGE followed by Western blotting. Blotted membranes were probed with a specific monoclonal anti-V5 antibody linked with horseradish peroxidase (Life Technologies), as specified in Figures 2 and 4B .
Subcellular localization of UGT1A1-mutated protein by differential centrifugation
HEK-293 cells were plated in 100-mm dishes (5× 10 6 cells/dish) and co-transfected for transient expression with 10 μg pUGT1A i1 using Lipofectine (Life Technologies). After 48 h, the cells were washed with PBS, harvested, centrifuged for 5 min at 888 g, resuspended in 500 μl of microsome buffer [2.62 mM KH 2 PO 4 , 1.38 mM K 2 HPO 4 , 20% glycerol (pH 7.0) and 0.5 mM DTT (dithiothreitol) freshly added] and frozen. The next day, the cytosolic and microsomal fractions were collected as follows: the cells were sonicated (5× 10 s on ice with a 10-s pause in between each sonication using 550 Sonic Dismembrator), centrifuged once at 12 200 g for 15 min and then the resulting supernatant was further centrifuged at 107 400 g for 1 h. The supernatant corresponded to the cytosolic fraction and the pellet to the microsomal fraction. Each fraction (80 μg of protein each) was resolved by SDS/PAGE followed by Western blotting, with the membrane blots probed using monoclonal anti-Myc tag antibodies (Cedarlane) followed by a secondary anti-mouse IgG antibodies linked with horseradish peroxidase (GE Healthcare).
RESULTS

Effect of deleted domains on the i1-i2 interaction
We first assessed whether the deletion of UGT1A-interacting domains reported previously to be critical in certain cases for enzyme function and those involved in subcellular localization might be relevant to protein-protein interactions between i1 and i2 proteins (summarized in Table 1 ). UGT1A1 was used as a prototype because homo-oligomerization has been well documented [28, 38, 39] . We generated ten mutant UGT1A1 proteins (Table 1 and Figure 1) . The engineered i1-Myc mutants were each co-transfected with either i1-V5 or i2-V5.
Figure 1 UGT protein domains and conserved cysteine residues
Schematic representation of UGT1A1 i1 protein in the ER membrane, showing the domains and localization of the cysteine residues. Most of the polypeptide resides in the ER lumen, except for the C-terminal tail and the transmembrane domain. The variable region confers substrate specificity and the conserved region is responsible for binding the co-substrate UDP-glucuronic acid. Each cysteine residue is represented by (᭡), except for Cys 18 ( ), which shows the N-terminal peptide being cleaved to produce the mature protein. Abbreviations of several domains that were deleted are also indicated.
Expression of mutant proteins was confirmed by Western blotting (results not shown) for all constructs. We initially performed co-immunoprecipitation control experiments to visualize the interaction between i1-i1, i1-i2 and i2-i2 (Figure 2A ) [18, 19] . Following transient expression, i1-Myc and its associated proteins were specifically pulled out from whole-cell extracts by immunoprecipitation using anti-Myc antibodies ( Figure 2B) . The immunoprecipitates were then assessed by SDS/PAGE and Western blotting, and an interaction between proteins was probed with anti-V5 antibodies.
The i1-i1 interaction was not detected in the absence of the SP ( SP) alone or with additional deletion of the TMD ( SP-TMD), although the interaction of i1 SP-TMD with i2 was detected. Deletion of the i1 TMD alone (i1 TMD) did not preclude the i1-i1 or i1-i2 interaction. Deletion of additional i1 domains, such as the MRA ( MRA), the first 150 residues ( 1-150), the end of exon 1 ( 180-250), the conserved region or signature sequence ( 250-375 and 375-490) or the C-terminus (L519X or K530X), did not prevent the interaction of either i1-i1 or i1-i2. On the basis of these observations, we also tested deletions within i2, i.e. the SP (i2 SP) and its first 150 residues (i2 1-150), each of which abolished the interaction with i1, but not with intact i2 (Figure 2C) . Part of the signature sequence and conserved C-terminal region of i2 (i2 375-444) was also deleted, and this did not prevent the interaction with i1 or intact i2.
As a missing domain of UGT1A1 could lead to its aberrant localization and thus erroneous interpretation of the coimmunoprecipitation results, subcellular fractionation was performed to confirm that each mutant protein indeed localized appropriately to the ER membrane to allow oligomerization with UGTs ( Figure 3) . The i1 SP mutant integrated into the ER membrane, but to a lesser extent compared with native UGT1A1 i1; we estimated that one half of the total i1 SP was in the cytosolic fraction, thus still leaving a substantial proportion of the protein available for interaction with native i1 in the ER. This translocation from the ER membrane to the cytosol was also observed for i1 SP-TMD. Deletion of other i1 domains, namely 1-150, TMD, L519X and K530X, did not affect the subcellular localization.
Disulfide bond analysis by SDS/PAGE under non-reducing conditions
A cellular heterologous expression system of UGT1A1 in HEK-293 cells was generated. Using antibodies directed against the tagged proteins of each UGT1A protein isoforms and in the absence of a strong reducing agent such as 2-mercaptoethanol, we observed monomeric UGT1As and also formation of the HMWC ( Figure 4A, left-hand panel) . Those monoclonal antibodies, antiMyc for i1 and anti-V5 for i2, were used to demonstrate the presence of i1 and i2 as monomers and as part of the HMWC. The HMWCs were absent from the parental HEK-293 cell line and were not observed in the presence of 2-mercaptoethanol, a reducing agent ( Figure 4A, right-hand panel) . Furthermore, the presence of UGT1A in these HMWCs, as determined by MS, was confirmed (results not shown); it is noteworthy that it was Lanes with odds numbers are immunoprecipitated with a polyclonal anti-Myc antibody, whereas the lanes with even numbers were left without immunoprecipitation antibody. Lanes 1-4, negative control; expression of either UGT1A1 i1-Myc or UGT1A1 i2-V5 alone. Lanes 5-10, positive control; lanes 5 and 6, control for UGT1A1 i1-Myc + UGT1A1 i2-V5 interaction; lanes 7 and 8, control for UGT1A1 i1-Myc + UGT1A1 i1-V5 interaction; lanes 9 and 10, control for UGT1A1 i2-Myc + UGT1A1 i2-V5 interaction. (B) Co-immunoprecipitation experiments with various UGT1A1 i1-myc mutant proteins with subsequent visualization of interacting partner UGT1A1 i1-V5 or UGT1A1 i2-V5 in the immunoprecipitation. A band corresponding to i1 is observed at the expected molecular mass (indicated on the right-hand side by the arrows) except for SP and SP TMD; in the latter case an unsure band is detected (B, lane 16). A band corresponding to i2 is observed in each corresponding wells. (C) Co-immunoprecipitation experiments of either UGT1A1 i2-Myc or UGT1A1 i1-Myc and with subsequent visualization of UGT1A1 i2-V5 mutated proteins. A band is detected at the expected molecular mass except for the interaction of i1-i2 SP and also i1-i2 1-150. For (B) and (C), the control lane (ctl) correspond to UGT1A1 i2-V5 full-length protein.
Each transfection and co-immunoprecipitation experiment was done at least twice as independent experiments. The vertical grey lanes indicates that there was a rearrangement or a grouping of the Western blot images. = deletion. not possible to discriminate between the highly similar i1 or i2 proteins by MS. In light of this observation and given that disulfide bonds are formed via oxidation of the thiol moiety of the cysteine residue, several cysteine residues present in UGT1A1 i1 were further mutated to tyrosine (Figure 1 ). Co-immunoprecipitation experiments revealed that these selected point mutations in i1 (Cys 18 Figure 4B and Table 2 ).
DISCUSSION
Identification of molecular interactions is an essential step towards a better understanding of cellular processes. Homo-and heterooligomerization of UGTs is well documented from independent studies [39] [40] [41] [42] [43] , and growing evidence suggests that these protein-protein interactions are one of the mechanisms by which i2 regulates cellular glucuronidation activity. We demonstrated previously that the splice variant UGT1A1 i2, which lacks the transmembrane helix encoded by exon 5a, interacts strongly with the full-length native UGT1A1 i1 [17] [18] [19] . However, the identity of the domain(s) mediating interactions between UGTs and their regulatory i2 partners is still unresolved. UGT1A1 i1 and i2 proteins have highly similar C-terminal portions, although i2 lacks the TMD encoded by exon 5a, suggesting that i2 does not require this membrane anchor for its interaction with i1. Similarly, deletion of the i1 TMD does not prevent i1-i2 interaction. However, we observed that deletion of N-terminal domains of UGT1A1 i1, such as the SP alone or with the TMD, precluded the i1-i1 interaction, but not that of i1-i2. The presence of the SP and the first 150 residues of i2 appear to be critical for the i1-i2 interaction, but not that of i2-i2. Conversely, the i1-i1 complex still formed even on deletion of the first 150 residues. These observations indicate that different domains are involved in native i1-i1 interactions compared with i1-i2 interactions. The SP of i1 enzymes is cleaved on insertion into the ER membrane, and thus the fact that its deletion affects the i1-i2 interaction is intriguing because it suggests a structural role for this domain in the i1-i2 interaction. In fact, our data support that only a fraction of the observed effect is attributable to mislocalization of mutated proteins in the cell. Thus it is possible that deletion of the i1 SP may impair its self-association owing to misfolding of the mutated i1 in the ER membrane, but the topology of mutated proteins was not assessed to confirm whether they were either located on the luminal or cytosolic side of the ER membrane. Differences between the domains involved in homoor hetero-oligomerization could be plausible because the topology of i2, which lacks a TMD in the ER membrane, may differ from that of i1. We suggested previously that localization/retention of i2 in the ER may be conferred, at least in part, by the dilysine motif KKXX encoded by the new exon 5b [27, 30] . Finally, it was not possible to infer protein-protein domains based on structural data owing to the extremely limited availability of three-dimensional structures for UGT [44] .
Deletion of other conserved domains of UGT1A1 i1, such as the MRA, reportedly substantially reduces its homo-oligomerization [28] . Conversely, and according to our observations, the MRA is probably not critical for i1-i2 interaction. The fact that i2 is enzymatically inactive suggests that the amino acid sequence encoded by exon 5a (residues 435-530) is required, functionally or structurally, for UGT1A1 transferase activity. However, deletion of the C-terminal region (TMD, L519X and K530X) does not affect the interacting potential between i1 and i2. Consistent with these observations, the TMD and the cytoplasmic 'tail' are not essential for functional oligomerization in the case of UGT1A9 [45] . However, the use of only one approach is a limitation of the present study, as the co-immunoprecipitation of mutated protein could lead to the misfolding of proteins. The results thus need to be confirmed with another approach. Another limitation is the fact that the co-immunoprecipitation results provide a qualitative outcome since the level of expression of mutated proteins, as well as their localization to the ER membrane, could be different from the full-length protein. The present paper remains the first to study the interaction between splice variant proteins derived for the UGT1A locus in humans.
The present study also evaluated the involvement of disulfide bonds between UGT1A isoforms on homo-and hetero-oligomerization, i.e. via SDS/PAGE under non-reducing conditions. Under these conditions, we could assess the presence of monomers and the formation of UGT oligomers. Our data are consistent with formation of oligomers with complexes migrating at 130-250 kDa. The presence of UGT in those complexes was further confirmed following tryptic digestion of bands extracted from gels and sequencing by MS. The data are thus consistent with previous reports indicating that disulfide bonds are indeed formed between UGTs [23, 28, 34] . UGT protein-protein interactions have also been studied under milder conditions using native-PAGE, which concluded that UGTs indeed oligomerize, probably in part via disulfide bonds [39, 43] . As cysteine residues are widely conserved among UGT1A subfamily members [46] , the study of their potential role in UGT protein-protein interactions is relevant. A cysteine-focused point mutation analysis did not compromise the interactions between UGT1A isoforms (i1-i1 or i1-i2). However, this analysis cannot rule out the possibility that a combination of cysteine residues may be responsible for the formation of HMWCs under non-reducing conditions. A study by Olson et al. [34] indicated that Cys 183 is involved in homodimerization of UGT1A9, although mutation of this codon to tyrosine ( Figure 4B ) or glycine (results not shown) in UGT1A1 i1 did not prevent its homo-or hetero-oligomerization with i2.
In conclusion, we report that i1-i2 interactions (either stable or transient) probably involve association between more than one domain that likely differs from those involved in i1-i1 interactions. Further investigations are needed for a fuller understanding of the interactions between i1 enzymes and their regulatory i2 partners.
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